---
figid: PMC9515217__41419_2022_5260_Fig7_HTML
pmcid: PMC9515217
image_filename: 41419_2022_5260_Fig7_HTML.jpg
figure_link: /pmc/articles/PMC9515217/figure/Fig7/
number: Fig. 7
figure_title: Treatment with the combination of alectinib and HI-032 suppressed tumor
  growth in vivo
caption: A, B Mice were treated by intraperitoneal injection with vehicle, alectinib,
  HI-032 or alectinib plus HI-032 for 20 days. Significant differences were determined
  by factorial analysis of variance. *P < 0.05, ***P < 0.001. C, D HE staining of
  liver and kidney among the four groups of animal study. Representative images were
  shown. Magnifications, ×40, ×200, scale bar = 100 µm.
article_title: Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive
  NSCLC.
citation: Juanjuan Xiao, et al. Cell Death Dis. 2022 Sep;13(9):828.
year: '2022'

doi: 10.1038/s41419-022-05260-3
journal_title: Cell Death & Disease
journal_nlm_ta: Cell Death Dis
publisher_name: Nature Publishing Group UK

keywords:
- Targeted therapies
- Growth factor signalling

---
